Oncology
NILIANT 150
Capsule — 150 mg
WHO-GMP
Product Overview
Nilotinib capsules are a targeted kinase inhibitor used to treat specific types of blood cancer, primarily newly diagnosed or resistant/intolerant Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in adult and pediatric patients
Indications
A cancer chemotherapy medication used to treat certain specific types of Chronic Myeloid Leukemia (CML)with a special genetic mutation and other types of CML that have not responded well to other cancer medications.
Dosage Forms & Strength
Available Forms
Capsule
Strength
150 mg
Regulatory Approvals
WHO-GMP